Complete remission in acute myeloid leukaemia after treatment with recombinant human granulocyte colony-stimulating factor and high dose intravenous methylprednisolone

Br J Haematol. 1991 Apr;77(4):561-2. doi: 10.1111/j.1365-2141.1991.tb08627.x.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Acute Disease
  • Adolescent
  • Drug Administration Schedule
  • Granulocyte Colony-Stimulating Factor / therapeutic use*
  • Humans
  • Leukemia, Myeloid / drug therapy*
  • Male
  • Methylprednisolone / administration & dosage
  • Methylprednisolone / therapeutic use*
  • Recombinant Proteins / therapeutic use
  • Remission Induction

Substances

  • Recombinant Proteins
  • Granulocyte Colony-Stimulating Factor
  • Methylprednisolone